|
| Status |
Public on Jul 08, 2019 |
| Title |
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [ChIP-Seq] |
| Organism |
Homo sapiens |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
To elucidate whether lncRNA-AF339830 plays a role in colorectal cancer tumorigenesis, a Chip-seq analysis was performed to compare the change of c-myc genome-wide binding of lncRNA-AF339830 siRNA and control siRNA transfectants.
|
| |
|
| Overall design |
Chip-seq was performed in DLD1 colorectal cancer cells after lncRNA-AF339830 knock down
|
| |
|
| Contributor(s) |
tingting Y |
| Citation(s) |
31375671 |
| Submission date |
Jun 18, 2019 |
| Last update date |
Aug 19, 2019 |
| Contact name |
Haoyan Chen |
| Organization name |
Renji Hospital
|
| Street address |
145 Shandong Road
|
| City |
Shanghai |
| State/province |
Shanghai |
| ZIP/Postal code |
200001 |
| Country |
China |
| |
|
| Platforms (1) |
| GPL21290 |
Illumina HiSeq 3000 (Homo sapiens) |
|
| Samples (2) |
| GSM3895624 |
Control siRNA (c-myc antibody treatment) |
| GSM3895625 |
lncRNA-AF339830 siRNA (c-myc antibody treatment) |
|
| This SubSeries is part of SuperSeries: |
| GSE132888 |
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc |
|
| Relations |
| BioProject |
PRJNA549398 |
| SRA |
SRP201716 |
